Cover Image
市場調查報告書

印度的體外診斷 (IVD) 市場未來展望:臨床化學,遺傳基因檢驗,血液檢驗,組織學、細胞學,免疫化學,感染疾病診斷,微生物培養

India In Vitro Diagnostics (IVD) Market Outlook to 2021 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture

出版商 GlobalData 商品編碼 349847
出版日期 內容資訊 英文 238 Pages
訂單完成後即時交付
價格
Back to Top
印度的體外診斷 (IVD) 市場未來展望:臨床化學,遺傳基因檢驗,血液檢驗,組織學、細胞學,免疫化學,感染疾病診斷,微生物培養 India In Vitro Diagnostics (IVD) Market Outlook to 2021 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture
出版日期: 2015年10月12日 內容資訊: 英文 238 Pages
簡介

本報告提供印度國內的體外診斷 (IVD) 用醫藥品的市場相關分析,整體市場趨勢預測 (以金額為準,過去、今後8年份) ,及各企業、各流通管道的市場佔有率,主要各市場區隔 (臨床化學、遺傳基因檢驗、血液檢驗、組織學&細胞學、免疫化學、感染疾病診斷、微生物培養) 詳細內容趨勢,主要的開發中產品和臨床實驗的進展,主要企業簡介,近來的市場主要動向等相關調查。

第1章 目錄

第2章 簡介

  • 本報告概要
  • 體外診斷 (IVD) 市場明細
  • 分析對象市場定義

第3章 印度的體外診斷 (IVD) 市場

  • 市場收益額趨勢預測 (總計15年份)
  • 市場收益額的結構
  • 市場收益額的明細:各類別
  • 各分類的市場收益額比較 (總計15年份)
  • 市場收益額的實際成果值 (過去8年份)
  • 市場收益額的預測值 (今後8年份)
  • 各企業的市場佔有率

第4章 印度臨床化學市場

  • 市場收益額的結構
  • 市場收益額的明細:各部門
  • 市場收益額的實際成果值 (過去8年份)
  • 市場收益額的預測值 (今後8年份)
    • 臨床化學分析設備的市場趨勢 (過去、今後8年份)
    • 治療藥監測的市場趨勢 (過去、今後8年份)
    • 尿液檢查的市場趨勢 (過去、今後8年份)
  • 各流通管道的市場佔有率
  • 各企業的市場佔有率

第5章 印度的遺傳基因檢驗市場

  • 市場收益額的結構
  • 市場收益額的明細:各部門
  • 市場收益額的實際成果值 (過去8年份)
  • 市場收益額的預測值 (今後8年份)
  • 各流通管道的市場佔有率
  • 各企業的市場佔有率

第6章 印度的血液檢驗市場

  • 市場收益額的結構
  • 市場收益額的明細:各部門
  • 市場收益額的實際成果值 (過去8年份)
  • 市場收益額的預測值 (今後8年份)
    • 血液細胞計數器的市場趨勢 (過去、今後8年份)
    • 迅速/POC (照護現場) 血液檢驗的市場趨勢 (過去、今後8年份)
    • 血液檢驗用試劑的市場趨勢 (過去、今後8年份)
    • 止血檢驗的市場趨勢 (過去、今後8年份)
    • 免疫血液學檢查的市場趨勢 (過去、今後8年份)
  • 各流通管道的市場佔有率
  • 各企業的市場佔有率

第7章 印度的組織學、細胞學市場

  • 市場收益額的結構
  • 市場收益額的明細:各部門
  • 市場收益額的實際成果值 (過去8年份)
  • 市場收益額的預測值 (今後8年份)
  • 各流通管道的市場佔有率
  • 各企業的市場佔有率

第8章 印度的免疫化學市場

  • 市場收益額的結構
  • 市場收益額的明細:各部門
  • 市場收益額的實際成果值 (過去8年份)
  • 市場收益額的預測值 (今後8年份)
    • 貧血症檢驗的市場趨勢 (過去、今後8年份)
    • 特定疾病的免疫化學療法的市場趨勢 (過去、今後8年份)
    • 內分泌檢查的市場趨勢 (過去、今後8年份)
    • IgE過敏血液檢驗的市場趨勢 (過去、今後8年份)
    • 免疫化學分析儀的市場趨勢 (過去、今後8年份)
    • 免疫化學用迅速/POC (照護現場) 檢驗的市場趨勢 (過去、今後8年份)
    • 維他命檢驗的市場趨勢 (過去、今後8年份)
  • 各流通管道的市場佔有率
  • 各企業的市場佔有率

第9章 印度的感染疾病診斷藥市場

  • 市場收益額的結構
  • 市場收益額的明細:各部門
  • 市場收益額的實際成果值 (過去8年份)
  • 市場收益額的預測值 (今後8年份)
    • 感染疾病診斷用迅速/POC (照護現場) 檢驗的市場趨勢 (過去、今後8年份)
  • 各流通管道的市場佔有率
  • 各企業的市場佔有率

第10章 印度的微生物培養市場

  • 市場收益額的結構
  • 市場收益額的明細:各部門
  • 市場收益額的實際成果值 (過去8年份)
  • 市場收益額的預測值 (今後8年份)
    • 微生物分析設備的市場趨勢 (過去、今後8年份)
  • 各流通管道的市場佔有率
  • 各企業的市場佔有率

第11章 主要企業簡介:印度的體外診斷市場

  • Siemens Healthcare
  • F. Hoffmann-La Roche Ltd.
  • Transasia Bio-Medicals Ltd.
  • Danaher Corporation
  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Sysmex
  • Himedia Laboratories Pvt. Ltd.
  • Trivitron Healthcare Pvt Ltd.
  • bioMerieux S.A.
  • Alere Inc.
  • PerkinElmer, Inc.
  • Bio-Rad Laboratories, Inc.
  • Span Diagnostics Ltd.
  • Agappe Diagnostics Ltd.
  • Ortho-Clinical Diagnostics Inc.

第12章 體外診斷市場開發中產品

第13章 資本交易環境

  • 企業收購 (共2件)
  • 股票上市 (1件)
  • 產業聯盟 (共30件)
  • 私人股權 (非上市股票交易) (1件)
  • 風險企業融資 (共2件)

第14章 近幾年趨勢

  • 來自企業的發表 (企業傳訊) (共2件)
  • 公佈財報 (共2件)
  • 其他主要動向 (共2件)
  • 產品新聞 (共2件)
  • 策略、產業計畫 (共4件)

第15章 附錄

圖表一覽

目錄
Product Code: GDMEMC0100DB

GlobalData's new report, "India In Vitro Diagnostics (IVD) Market Outlook to 2021 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture", provides key market data on the India In Vitro Diagnostics market. The report provides value, in millions of US dollars within market segments - Immuno Chemistry, Clinical Chemistry, Infectious Diagnostics, Haematology, Microbiology Culture, Histology and Cytology and Genetic Testing.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • In Vitro Diagnostics market includes Immuno Chemistry, Clinical Chemistry, Infectious Diagnostics, Haematology, Microbiology Culture, Histology and Cytology and Genetic Testing.
  • Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
  • 2014 company shares and distribution shares data for In Vitro Diagnostics market.
  • Global corporate-level profiles of key companies operating within the India In Vitro Diagnostics market.
  • Key players covered include F. Hoffmann-La Roche Ltd., Siemens Healthcare, Abbott Laboratories, bioMerieux S.A., Danaher Corporation, Ortho-Clinical Diagnostics Inc. Becton, Dickinson and Company, Bio-Rad Laboratories, Inc. and Others.

Reasons to buy

  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. What Is This Report About?
  • 2.2. In Vitro Diagnostics Market Segmentation
  • 2.3. Definitions of Markets Covered in the Report

3. In Vitro Diagnostics Market, India

  • 3.1. In Vitro Diagnostics Market, India, Revenue ($m), 2007-2021
  • 3.2. In Vitro Diagnostics Market, India, Revenue Mix ($m), 2014
  • 3.3. In Vitro Diagnostics Market, India, Category Contribution by Revenue ($m), 2014
  • 3.4. In Vitro Diagnostics Market, Japan, Category Comparison by Revenue ($m), 2007-2021
  • 3.5. In Vitro Diagnostics Market, India, Revenue ($m), 2007-2014
  • 3.6. In Vitro Diagnostics Market, India, Revenue ($m), 2014-2021
  • 3.7. In Vitro Diagnostics Market, India, Company Share by Revenue ($m), 2014

4. Clinical Chemistry Market, India

  • 4.1. Clinical Chemistry Market, India, Revenue Mix ($m), 2014
  • 4.2. Clinical Chemistry Market, India, Segment Contribution (%), 2014
  • 4.3. Clinical Chemistry Market, India, Revenue ($m), 2007-2014
  • 4.4. Clinical Chemistry Market, India, Revenue ($m), 2014-2021
    • 4.4.1. Clinical Chemistry Analyzers Market, India, Revenue ($m), by Segment, 2007-2014
    • 4.4.2. Therapeutic Drug Monitoring Market, India, Revenue ($m), by Segment, 2007-2014
    • 4.4.3. Urine Analysis Market, India, Revenue ($m), by Segment, 2007-2014
    • 4.4.4. Clinical Chemistry Analyzers Market, India, Revenue ($m), by Segment, 2014-2021
    • 4.4.5. Therapeutic Drug Monitoring Market, India, Revenue ($m), by Segment, 2014-2021
    • 4.4.6. Urine Analysis Market, India, Revenue ($m), by Segment, 2014-2021
  • 4.5. Clinical Chemistry Market, India, Distribution Share by Revenue ($m), 2013-2014
  • 4.6. Clinical Chemistry Market, India, Company Share by Revenue ($m), 2014

5. Genetic Testing Market, India

  • 5.1. Genetic Testing Market, India, Revenue Mix ($m), 2014
  • 5.2. Genetic Testing Market, India, Segment Contribution (%), 2014
  • 5.3. Genetic Testing Market, India, Revenue ($m), 2007-2014
  • 5.4. Genetic Testing Market, India, Revenue ($m), 2014-2021
  • 5.5. Genetic Testing Market, India, Distribution Share by Revenue ($m), 2013-2014
  • 5.6. Genetic Testing Market, India, Company Share by Revenue ($m), 2014

6. Haematology Market, India

  • 6.1. Haematology Market, India, Revenue Mix ($m), 2014
  • 6.2. Haematology Market, India, Segment Contribution (%), 2014
  • 6.3. Haematology Market, India, Revenue ($m), 2007-2014
  • 6.4. Haematology Market, India, Revenue ($m), 2014-2021
    • 6.4.1. Haematology Cell Counters Market, India, Revenue ($m), by Segment, 2007-2014
    • 6.4.2. Haematology Rapid Tests & POC Market, India, Revenue ($m), by Segment, 2007-2014
    • 6.4.3. Haematology Reagents Market, India, Revenue ($m), by Segment, 2007-2014
    • 6.4.4. Haemostasis Market, India, Revenue ($m), by Segment, 2007-2014
    • 6.4.5. Immunohaematology Market, India, Revenue ($m), by Segment, 2007-2014
    • 6.4.6. Haematology Cell Counters Market, India, Revenue ($m), by Segment, 2014-2021
    • 6.4.7. Haematology Rapid Tests & POC Market, India, Revenue ($m), by Segment, 2014-2021
    • 6.4.8. Haematology Reagents Market, India, Revenue ($m), by Segment, 2014-2021
    • 6.4.9. Haemostasis Market, India, Revenue ($m), by Segment, 2014-2021
    • 6.4.10. Immunohaematology Market, India, Revenue ($m), by Segment, 2014-2021
  • 6.5. Haematology Market, India, Distribution Share by Revenue ($m), 2013-2014
  • 6.6. Haematology Market, India, Company Share by Revenue ($m), 2014

7. Histology And Cytology Market, India

  • 7.1. Histology And Cytology Market, India, Revenue Mix ($m), 2014
  • 7.2. Histology And Cytology Market, India, Segment Contribution (%), 2014
  • 7.3. Histology And Cytology Market, India, Revenue ($m), 2007-2014
  • 7.4. Histology And Cytology Market, India, Revenue ($m), 2014-2021
  • 7.5. Histology And Cytology Market, India, Distribution Share by Revenue ($m), 2013-2014
  • 7.6. Histology And Cytology Market, India, Company Share by Revenue ($m), 2014

8. Immuno Chemistry Market, India

  • 8.1. Immuno Chemistry Market, India, Revenue Mix ($m), 2014
  • 8.2. Immuno Chemistry Market, India, Segment Contribution (%), 2014
  • 8.3. Immuno Chemistry Market, India, Revenue ($m), 2007-2014
  • 8.4. Immuno Chemistry Market, India, Revenue ($m), 2014-2021
    • 8.4.1. Anemia Tests Market, India, Revenue ($m), by Segment, 2007-2014
    • 8.4.2. Disease Specific Immunochemistry Market, India, Revenue ($m), by Segment, 2007-2014
    • 8.4.3. Endocrinology Tests Market, India, Revenue ($m), by Segment, 2007-2014
    • 8.4.4. IgE Allergy Blood Tests Market, India, Revenue ($m), by Segment, 2007-2014
    • 8.4.5. Immunochemistry Analyzers Market, India, Revenue ($m), by Segment, 2007-2014
    • 8.4.6. Immunochemistry Rapid Tests & POC Market, India, Revenue ($m), by Segment, 2007-2014
    • 8.4.7. Vitamins Tests Market, India, Revenue ($m), by Segment, 2007-2014
    • 8.4.8. Anemia Tests Market, India, Revenue ($m), by Segment, 2014-2021
    • 8.4.9. Disease Specific Immunochemistry Market, India, Revenue ($m), by Segment, 2014-2021
    • 8.4.10. Endocrinology Tests Market, India, Revenue ($m), by Segment, 2014-2021
    • 8.4.11. IgE Allergy Blood Tests Market, India, Revenue ($m), by Segment, 2014-2021
    • 8.4.12. Immunochemistry Analyzers Market, India, Revenue ($m), by Segment, 2014-2021
    • 8.4.13. Immunochemistry Rapid Tests & POC Market, India, Revenue ($m), by Segment, 2014-2021
    • 8.4.14. Vitamins Tests Market, India, Revenue ($m), by Segment, 2014-2021
  • 8.5. Immuno Chemistry Market, India, Distribution Share by Revenue ($m), 2013-2014
  • 8.6. Immuno Chemistry Market, India, Company Share by Revenue ($m), 2014

9. Infectious Diagnostics Market, India

  • 9.1. Infectious Diagnostics Market, India, Revenue Mix ($m), 2014
  • 9.2. Infectious Diagnostics Market, India, Segment Contribution (%), 2014
  • 9.3. Infectious Diagnostics Market, India, Revenue ($m), 2007-2014
  • 9.4. Infectious Diagnostics Market, India, Revenue ($m), 2014-2021
    • 3.2.1. Infectious Diagnostics Rapid Tests & POC Market, India, Revenue ($m), by Segment, 2007-2014
    • 3.2.2. Infectious Diagnostics Rapid Tests & POC Market, India, Revenue ($m), by Segment, 2014-2021
  • 9.5. Infectious Diagnostics Market, India, Distribution Share by Revenue ($m), 2013-2014
  • 9.6. Infectious Diagnostics Market, India, Company Share by Revenue ($m), 2014

10. Microbiology Culture Market, India

  • 10.1. Microbiology Culture Market, India, Revenue Mix ($m), 2014
  • 10.2. Microbiology Culture Market, India, Segment Contribution (%), 2014
  • 10.3. Microbiology Culture Market, India, Revenue ($m), 2007-2014
  • 10.4. Microbiology Culture Market, India, Revenue ($m), 2014-2021
    • 10.4.1. Microbiology Analyzers Market, India, Revenue ($m), by Segment, 2007-2014
    • 10.4.2. Microbiology Analyzers Market, India, Revenue ($m), by Segment, 2014-2021
  • 10.5. Microbiology Culture Market, India, Distribution Share by Revenue ($m), 2013-2014
  • 10.6. Microbiology Culture Market, India, Company Share by Revenue ($m), 2014

11. Overview of Key Companies in India, In Vitro Diagnostics Market

  • 11.1. Siemens Healthcare
    • 11.1.1. Company Overview
  • 11.2. F. Hoffmann-La Roche Ltd.
    • 11.2.1. Company Overview
  • 11.3. Transasia Bio-Medicals Ltd.
    • 11.3.1. Company Overview
  • 11.4. Danaher Corporation
    • 11.4.1. Company Overview
  • 11.5. Abbott Laboratories
    • 11.5.1. Company Overview
  • 11.6. Becton, Dickinson and Company
    • 11.6.1. Company Overview
  • 11.7. Sysmex Corporation
    • 11.7.1. Company Overview
  • 11.8. Himedia Laboratories Pvt. Ltd.
    • 11.8.1. Company Overview
  • 11.9. Trivitron Healthcare Pvt Ltd.
    • 11.9.1. Company Overview
  • 11.10. bioMerieux S.A.
    • 11.10.1. Company Overview
  • 11.11. Alere Inc.
    • 11.11.1. Company Overview
  • 11.12. PerkinElmer, Inc.
    • 11.12.1. Company Overview
  • 11.13. Bio-Rad Laboratories, Inc.
    • 11.13.1. Company Overview
  • 11.14. Span Diagnostics Ltd.
    • 11.14.1. Company Overview
  • 11.15. Agappe Diagnostics Ltd.
    • 11.15.1. Company Overview
  • 11.16. Ortho-Clinical Diagnostics Inc.
    • 11.16.1. Company Overview

12. In Vitro Diagnostics Market Pipeline Products

13. Financial Deals Landscape

  • 13.1. Acquisition
    • 13.1.1. Tosoh Acquires Lilac Medicare, In-Vitro Diagnostics Company
    • 13.1.2. Span Diagnostics to Divest 45% Stake in Span Nihon Kohden Diagnostics to Nihon Kohden
  • 13.2. Equity Offerings
    • 13.2.1. Transasia Bio-Medicals Plans to Raise Funds through IPO
  • 13.3. Partnerships
    • 13.3.1. Curetis Enters into Licensing Agreement with Acumen Research Labs for AcuSept
    • 13.3.2. Seegene Enters into Co-Development Agreement with BD Life Sciences
    • 13.3.3. OriGene Technologies Enters into Licensing Agreement with Diadexus
    • 13.3.4. MdxHealth Enters into Licensing Agreement with Erasmus MC
    • 13.3.5. Instrumentation Laboratory Company Enters into Partnership with Thermo Fisher Scientific
    • 13.3.6. Sigma-Aldrich Enters into Distribution Agreement with LGC
    • 13.3.7. OvaGene Oncology Enters into Agreement with Etta Healthcare
    • 13.3.8. InTouch Health Enters into Agreement with iSchemaView
    • 13.3.9. IBA Partners with Philips India
    • 13.3.10. Halozyme Therapeutics Enters into Co-Development Agreement with Ventana Medical Systems for Cancer Treatment
    • 13.3.11. Courtagen Life Sciences Enter into Distribution Agreement with Pronto Diagnostics for Next Generation Sequencing Tests
    • 13.3.12. DiaCarta Enters into Licensing Agreement with University of Potsdam for Colon Cancer Test
    • 13.3.13. IncellDx Enters into Licensing Agreement with Claremont BioSolutions
    • 13.3.14. Abbott Labs Enters into Agreement with Sekisui Diagnostics for Coagulation Testing
    • 13.3.15. AngioDynamics Enters into Licensing Agreement with EmboMedics
    • 13.3.16. Ion Beam Applications Enters into Distribution Agreement with Toshiba Medical Systems
    • 13.3.17. Applied BioCode Expands Licensing Agreement with PerkinElmer for Barcoded Magnetic Bead Technology
    • 13.3.18. Biocartis Enters into Licensing and Development Agreement with Microbiome
    • 13.3.19. CBScientific Enters into Distribution Agreement with UTest
    • 13.3.20. GeneThera Enters into Co-Development Agreement with Hudson Robotics
    • 13.3.21. Nanospeed Enters into Distribution Agreement with DiaSys for Test4D
    • 13.3.22. Sapien Biosciences Enters into Development Agreement with OncoStem Diagnostics
    • 13.3.23. Genomic Vision Extends Agreement with Quest Diagnostics
    • 13.3.24. Ortho-Clinical Enters into Distribution Agreement with Quotient for MosaiQ
    • 13.3.25. Advanced Biological Labs, Inserm Transfert and Centre Hospitalier Universitaire Enter into Licensing Agreement for PyroVir software
    • 13.3.26. BioMerieux Enters into Licensing Agreement with Astute Medical
    • 13.3.27. MdxHealth Enters into Licensing Agreement with Oncgnostics for Epigenetic PCR Technology
    • 13.3.28. NoemaLife Enters into Distribution Agreement with Horiba Medical
    • 13.3.29. Foundation for Innovative New Diagnostics Enters into Agreement with Molbio Diagnostics
    • 13.3.30. Clinical Genomics Enters into Licensing Agreement with CSIRO
  • 13.4. Private Equity
    • 13.4.1. Manipal Education and Medical Group International May Acquire Medall Healthcare
  • 13.5. Venture Financing
    • 13.5.1. Wrig Nanosystems Raises USD2.3 Million
    • 13.5.2. Mapmygenome Raises USD1.1 Million in Pre-Series A Venture Financing

14. Recent Developments

  • 14.1. Corporate Communications
    • 14.1.1. Jun 08, 2015: Celator Pharmaceuticals Announces Expansion of Clinical Study in Patients with Untreated Myelodysplastic Syndrome or Acute Myeloid Leukemia at High-Risk of Treatment-Related Mortality
    • 14.1.2. Nov 12, 2014: Popular Science Recognizes Convergent Dental's Solea CO2 Laser with Best of What's New Award
  • 14.2. Financial Announcements
    • 14.2.1. Dec 13, 2014: Sri Ramakrishna Hospital Inaugurates Discovery IQ PET/CT System In Tamil Nadu, India
    • 14.2.2. Nov 13, 2014: Morepen Laboratories Reports Revenue Of INR1.7 Billion In H1 Fiscal 2014
  • 14.3. Other Significant Developments
    • 14.3.1. Aug 18, 2015: Ortho Clinical Diagnostics Selects Model N for Global Deployment of Revvy Configure Price Quote for Medical Technologies
    • 14.3.2. Nov 05, 2014: Bearing Analytics Changes Name To DATTUS, Opens Office In India
  • 14.4. Product News
    • 14.4.1. Apr 21, 2015: Cancer Genetics Expands Next-Generation Sequencing Capabilities in India Through Launch of Solid Tumor Hotspot Panel for Biopharma and Clinical Customers Throughout Asia
    • 14.4.2. Mar 03, 2015: Molbio Diagnostics Develops Swine Flu Diagnostic Kit
  • 14.5. Strategy And Business Planning
    • 14.5.1. Aug 26, 2015: Pressure BioSciences and the Institute of Bioinformatics Announce Comprehensive Two Year Collaboration
    • 14.5.2. Dec 21, 2014: Siemens Healthcare Likely To Expand Manufacturing Base In India
    • 14.5.3. Nov 06, 2014: Takeda Announces Abstracts for Ixazomib in Multiple Myeloma to be Presented at 56th American Society of Hematology Annual Meeting
    • 14.5.4. Nov 06, 2014: Analytik Jena Establishes Subsidiary in India

15. Appendix

  • 15.1. Research Methodology
    • 15.1.1. Coverage
    • 15.1.2. Secondary Research
    • 15.1.3. Primary Research
    • 15.1.4. Company Share Analysis
    • 15.1.5. Distribution Share Analysis
  • 15.2. GlobalData Consulting
  • 15.3. Contact Us
  • 15.4. Disclaimer

List of Tables

  • Table 1: In Vitro Diagnostics Market, India, Revenue ($m), USD Constant, 2007-2021
  • Table 2: In Vitro Diagnostics Market, India, Category Contribution by Revenue ($m), 2014
  • Table 3: In Vitro Diagnostics Market, Japan, Category Comparison by Revenue ($m), USD Constant, 2007-2021
  • Table 4: In Vitro Diagnostics Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 5: In Vitro Diagnostics Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 6: In Vitro Diagnostics Market, India, Company Share by Revenue ($m), USD Constant, 2014
  • Table 7: Clinical Chemistry Market, India, Segment Contribution (%), 2014
  • Table 8: Clinical Chemistry Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 9: Clinical Chemistry Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 10: Clinical Chemistry Analyzers Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 11: Therapeutic Drug Monitoring Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 12: Urine Analysis Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 13: Clinical Chemistry Analyzers Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 14: Therapeutic Drug Monitoring Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 15: Urine Analysis Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 16: Clinical Chemistry Market, India, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 17: Clinical Chemistry Market, India, Company Share by Revenue ($m), USD Constant, 2014
  • Table 18: Genetic Testing Market, India, Segment Contribution (%), 2014
  • Table 19: Genetic Testing Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 20: Genetic Testing Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 21: Genetic Testing Market, India, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 22: Genetic Testing Market, India, Company Share by Revenue ($m), USD Constant, 2014
  • Table 23: Haematology Market, India, Segment Contribution (%), 2014
  • Table 24: Haematology Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 25: Haematology Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 26: Haematology Cell Counters Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 27: Haematology Rapid Tests & POC Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 28: Haematology Reagents Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 29: Haemostasis Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 30: Immunohaematology Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 31: Haematology Cell Counters Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 32: Haematology Rapid Tests & POC Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 33: Haematology Reagents Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 34: Haemostasis Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 35: Immunohaematology Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 36: Haematology Market, India, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 37: Haematology Market, India, Company Share by Revenue ($m), USD Constant, 2014
  • Table 38: Histology And Cytology Market, India, Segment Contribution (%), 2014
  • Table 39: Histology And Cytology Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 40: Histology And Cytology Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 41: Histology And Cytology Market, India, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 42: Histology And Cytology Market, India, Company Share by Revenue ($m), USD Constant, 2014
  • Table 43: Immuno Chemistry Market, India, Segment Contribution (%), 2014
  • Table 44: Immuno Chemistry Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 45: Immuno Chemistry Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 46: Anemia Tests Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 47: Disease Specific Immunochemistry Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 48: Endocrinology Tests Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 49: IgE Allergy Blood Tests Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 50: Immunochemistry Analyzers Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 51: Immunochemistry Rapid Tests & POC Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 52: Vitamins Tests Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 53: Anemia Tests Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 54: Disease Specific Immunochemistry Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 55: Endocrinology Tests Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 56: IgE Allergy Blood Tests Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 57: Immunochemistry Analyzers Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 58: Immunochemistry Rapid Tests & POC Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 59: Vitamins Tests Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 60: Immuno Chemistry Market, India, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 61: Immuno Chemistry Market, India, Company Share by Revenue ($m), USD Constant, 2014
  • Table 62: Infectious Diagnostics Market, India, Segment Contribution (%), 2014
  • Table 63: Infectious Diagnostics Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 64: Infectious Diagnostics Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 65: Infectious Diagnostics Rapid Tests & POC Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 66: Infectious Diagnostics Rapid Tests & POC Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 67: Infectious Diagnostics Market, India, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 68: Infectious Diagnostics Market, India, Company Share by Revenue ($m), USD Constant, 2014
  • Table 69: Microbiology Culture Market, India, Segment Contribution (%), 2014
  • Table 70: Microbiology Culture Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 71: Microbiology Culture Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 72: Microbiology Analyzers Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 73: Microbiology Analyzers Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 74: Microbiology Culture Market, India, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 75: Microbiology Culture Market, India, Company Share by Revenue ($m), USD Constant, 2014
  • Table 76: In Vitro Diagnostics Market Pipeline Products
  • Table 77: Tosoh Acquires Lilac Medicare, In-Vitro Diagnostics Company
  • Table 78: Span Diagnostics to Divest 45% Stake in Span Nihon Kohden Diagnostics to Nihon Kohden
  • Table 79: Transasia Bio-Medicals Plans to Raise Funds through IPO
  • Table 80: Curetis Enters into Licensing Agreement with Acumen Research Labs for AcuSept
  • Table 81: Seegene Enters into Co-Development Agreement with BD Life Sciences
  • Table 82: OriGene Technologies Enters into Licensing Agreement with Diadexus
  • Table 83: MdxHealth Enters into Licensing Agreement with Erasmus MC
  • Table 84: Instrumentation Laboratory Company Enters into Partnership with Thermo Fisher Scientific
  • Table 85: Sigma-Aldrich Enters into Distribution Agreement with LGC
  • Table 86: OvaGene Oncology Enters into Agreement with Etta Healthcare
  • Table 87: InTouch Health Enters into Agreement with iSchemaView
  • Table 88: IBA Partners with Philips India
  • Table 89: Halozyme Therapeutics Enters into Co-Development Agreement with Ventana Medical Systems for Cancer Treatment
  • Table 90: Courtagen Life Sciences Enter into Distribution Agreement with Pronto Diagnostics for Next Generation Sequencing Tests
  • Table 91: DiaCarta Enters into Licensing Agreement with University of Potsdam for Colon Cancer Test
  • Table 92: IncellDx Enters into Licensing Agreement with Claremont BioSolutions
  • Table 93: Abbott Labs Enters into Agreement with Sekisui Diagnostics for Coagulation Testing
  • Table 94: AngioDynamics Enters into Licensing Agreement with EmboMedics
  • Table 95: Ion Beam Applications Enters into Distribution Agreement with Toshiba Medical Systems
  • Table 96: Applied BioCode Expands Licensing Agreement with PerkinElmer for Barcoded Magnetic Bead Technology
  • Table 97: Biocartis Enters into Licensing and Development Agreement with Microbiome
  • Table 98: CBScientific Enters into Distribution Agreement with UTest
  • Table 99: GeneThera Enters into Co-Development Agreement with Hudson Robotics
  • Table 100: Nanospeed Enters into Distribution Agreement with DiaSys for Test4D
  • Table 101: Sapien Biosciences Enters into Development Agreement with OncoStem Diagnostics
  • Table 102: Genomic Vision Extends Agreement with Quest Diagnostics
  • Table 103: Ortho-Clinical Enters into Distribution Agreement with Quotient for MosaiQ
  • Table 104: Advanced Biological Labs, Inserm Transfert and Centre Hospitalier Universitaire Enter into Licensing Agreement for PyroVir software
  • Table 105: BioMerieux Enters into Licensing Agreement with Astute Medical
  • Table 106: MdxHealth Enters into Licensing Agreement with Oncgnostics for Epigenetic PCR Technology
  • Table 107: NoemaLife Enters into Distribution Agreement with Horiba Medical
  • Table 108: Foundation for Innovative New Diagnostics Enters into Agreement with Molbio Diagnostics
  • Table 109: Clinical Genomics Enters into Licensing Agreement with CSIRO
  • Table 110: Manipal Education and Medical Group International May Acquire Medall Healthcare
  • Table 111: Wrig Nanosystems Raises USD2.3 Million
  • Table 112: Mapmygenome Raises USD1.1 Million in Pre-Series A Venture Financing

List of Figures

  • Figure 1: In Vitro Diagnostics Market, India, Revenue ($m), USD Constant, 2007-2021
  • Figure 2: In Vitro Diagnostics Market, India, Revenue Mix ($m), 2014
  • Figure 3: In Vitro Diagnostics Market, India, Category Contribution (%), 2014
  • Figure 4: In Vitro Diagnostics Market, Japan, Category Comparison by Revenue ($m), USD Constant, 2007-2021
  • Figure 5: In Vitro Diagnostics Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 6: In Vitro Diagnostics Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 7: In Vitro Diagnostics Market, India, Company Share (%) 2014
  • Figure 8: Clinical Chemistry Market, India, Revenue Mix ($m), 2014
  • Figure 9: Clinical Chemistry Market, India, Segment Contribution (%), 2014
  • Figure 10: Clinical Chemistry Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 11: Clinical Chemistry Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 12: Clinical Chemistry Analyzers Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 13: Therapeutic Drug Monitoring Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 14: Urine Analysis Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 15: Clinical Chemistry Analyzers Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 16: Therapeutic Drug Monitoring Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 17: Urine Analysis Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 18: Clinical Chemistry Market, India, Company Share (%) 2014
  • Figure 19: Genetic Testing Market, India, Revenue Mix ($m), 2014
  • Figure 20: Genetic Testing Market, India, Segment Contribution (%), 2014
  • Figure 21: Genetic Testing Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 22: Genetic Testing Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 23: Genetic Testing Market, India, Company Share (%) 2014
  • Figure 24: Haematology Market, India, Revenue Mix ($m), 2014
  • Figure 25: Haematology Market, India, Segment Contribution (%), 2014
  • Figure 26: Haematology Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 27: Haematology Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 28: Haematology Cell Counters Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 29: Haematology Rapid Tests & POC Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 30: Haematology Reagents Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 31: Haemostasis Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 32: Immunohaematology Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 33: Haematology Cell Counters Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 34: Haematology Rapid Tests & POC Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 35: Haematology Reagents Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 36: Haemostasis Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 37: Immunohaematology Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 38: Haematology Market, India, Company Share (%) 2014
  • Figure 39: Histology And Cytology Market, India, Revenue Mix ($m), 2014
  • Figure 40: Histology And Cytology Market, India, Segment Contribution (%), 2014
  • Figure 41: Histology And Cytology Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 42: Histology And Cytology Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 43: Histology And Cytology Market, India, Company Share (%) 2014
  • Figure 44: Immuno Chemistry Market, India, Revenue Mix ($m), 2014
  • Figure 45: Immuno Chemistry Market, India, Segment Contribution (%), 2014
  • Figure 46: Immuno Chemistry Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 47: Immuno Chemistry Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 48: Anemia Tests Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 49: Disease Specific Immunochemistry Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 50: Endocrinology Tests Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 51: IgE Allergy Blood Tests Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 52: Immunochemistry Analyzers Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 53: Immunochemistry Rapid Tests & POC Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 54: Vitamins Tests Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 55: Anemia Tests Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 56: Disease Specific Immunochemistry Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 57: Endocrinology Tests Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 58: IgE Allergy Blood Tests Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 59: Immunochemistry Analyzers Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 60: Immunochemistry Rapid Tests & POC Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 61: Vitamins Tests Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 62: Immuno Chemistry Market, India, Company Share (%) 2014
  • Figure 63: Infectious Diagnostics Market, India, Revenue Mix ($m), 2014
  • Figure 64: Infectious Diagnostics Market, India, Segment Contribution (%), 2014
  • Figure 65: Infectious Diagnostics Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 66: Infectious Diagnostics Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 67: Infectious Diagnostics Rapid Tests & POC Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 68: Infectious Diagnostics Rapid Tests & POC Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 69: Infectious Diagnostics Market, India, Company Share (%) 2014
  • Figure 70: Microbiology Culture Market, India, Revenue Mix ($m), 2014
  • Figure 71: Microbiology Culture Market, India, Segment Contribution (%), 2014
  • Figure 72: Microbiology Culture Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 73: Microbiology Culture Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 74: Microbiology Analyzers Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 75: Microbiology Analyzers Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 76: Microbiology Culture Market, India, Company Share (%) 2014
Back to Top